$AMGN News

AMGEN TO PRESENT NEW DATA ACROSS RARE AUTOIMMUNE AND INFLAMMATORY DISEASES AT EULAR 2026

Reported June 1, 2026: European Commission Approves Amgen's IMDYLLTRA For The Treatment Of Extensive-Stage Small Cell Lung Cancer

Amgen Secures EU Nod for Imdylltra in Lung Cancer Indication

How The Amgen (AMGN) Story Is Evolving As Rare Disease Upside Meets Valuation Caution

Amgen Stock: Is AMGN Outperforming the Healthcare Sector?

AMGEN TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE

Possible Bearish Signals With Amgen Insiders Disposing Stock

Amgen Ventures Invests In Ember LifeSciences; Terms Undisclosed

Amgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know

Amgen's Growth Engine Is Just Getting Started

Amgen (AMGN) Announces Retirement of CFO Peter Griffith

CFOs On the Move: Week ending May 22

A Look At Amgen (AMGN) Valuation As Tavneos Safety Concerns And Withdrawal Requests Escalate

Amgen’s ‘boomerang’ CFO reaps $12.5M in cash, retention bonuses

Amgen Inc. (AMGN): Navellier’s Long-Term Pick on Pipeline Strength and Sales Growth

This AI Biotech Stock Landed a $10.4 Million Nvidia Investment

3 Large-Cap Stocks Worth Investigating

AMGEN ANNOUNCES RETIREMENT OF CHIEF FINANCIAL OFFICER PETER GRIFFITH

Amgen (AMGN) Gets Price Target Cut at Piper Sandler Despite Long-Term Growth Optimism

Update: Amgen Kidney Disease Drug Under Scrutiny in Japan